logo
Are Auto-Tires-Trucks Stocks Lagging PHINIA Inc. (PHIN) This Year?

Are Auto-Tires-Trucks Stocks Lagging PHINIA Inc. (PHIN) This Year?

Yahoo3 days ago
The Auto-Tires-Trucks group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Phinia (PHIN) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Auto-Tires-Trucks sector should help us answer this question.
Phinia is one of 96 companies in the Auto-Tires-Trucks group. The Auto-Tires-Trucks group currently sits at #11 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Phinia is currently sporting a Zacks Rank of #1 (Strong Buy).
The Zacks Consensus Estimate for PHIN's full-year earnings has moved 6.8% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Based on the most recent data, PHIN has returned 11.8% so far this year. Meanwhile, the Auto-Tires-Trucks sector has returned an average of -10.4% on a year-to-date basis. As we can see, Phinia is performing better than its sector in the calendar year.
One other Auto-Tires-Trucks stock that has outperformed the sector so far this year is QuantumScape Corporation (QS). The stock is up 111.6% year-to-date.
In QuantumScape Corporation's case, the consensus EPS estimate for the current year increased 3.5% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Phinia belongs to the Automotive - Original Equipment industry, a group that includes 50 individual stocks and currently sits at #74 in the Zacks Industry Rank. On average, this group has gained an average of 11.3% so far this year, meaning that PHIN is performing better in terms of year-to-date returns. QuantumScape Corporation is also part of the same industry.
Going forward, investors interested in Auto-Tires-Trucks stocks should continue to pay close attention to Phinia and QuantumScape Corporation as they could maintain their solid performance.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
PHINIA Inc. (PHIN) : Free Stock Analysis Report
QuantumScape Corporation (QS) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Costco (COST) Increases Despite Market Slip: Here's What You Need to Know
Costco (COST) Increases Despite Market Slip: Here's What You Need to Know

Yahoo

time12 minutes ago

  • Yahoo

Costco (COST) Increases Despite Market Slip: Here's What You Need to Know

Costco (COST) closed the most recent trading day at $952.36, moving +1.35% from the previous trading session. The stock outpaced the S&P 500's daily loss of 1.6%. On the other hand, the Dow registered a loss of 1.23%, and the technology-centric Nasdaq decreased by 2.24%. Heading into today, shares of the warehouse club operator had lost 4.8% over the past month, lagging the Retail-Wholesale sector's gain of 2.64% and the S&P 500's gain of 2.25%. Investors will be eagerly watching for the performance of Costco in its upcoming earnings disclosure. The company is forecasted to report an EPS of $5.8, showcasing a 12.62% upward movement from the corresponding quarter of the prior year. Meanwhile, our latest consensus estimate is calling for revenue of $85.83 billion, up 7.7% from the prior-year quarter. COST's full-year Zacks Consensus Estimates are calling for earnings of $17.97 per share and revenue of $274.97 billion. These results would represent year-over-year changes of +11.55% and +8.06%, respectively. Investors might also notice recent changes to analyst estimates for Costco. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits. Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.39% lower. Costco presently features a Zacks Rank of #3 (Hold). Looking at valuation, Costco is presently trading at a Forward P/E ratio of 52.3. This expresses a premium compared to the average Forward P/E of 21.93 of its industry. We can additionally observe that COST currently boasts a PEG ratio of 5.84. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Retail - Discount Stores stocks are, on average, holding a PEG ratio of 2.61 based on yesterday's closing prices. The Retail - Discount Stores industry is part of the Retail-Wholesale sector. Currently, this industry holds a Zacks Industry Rank of 169, positioning it in the bottom 32% of all 250+ industries. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to use to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Costco Wholesale Corporation (COST) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

Flora Growth Corp. (FLGC) Reports Q2 Loss, Tops Revenue Estimates
Flora Growth Corp. (FLGC) Reports Q2 Loss, Tops Revenue Estimates

Yahoo

time12 minutes ago

  • Yahoo

Flora Growth Corp. (FLGC) Reports Q2 Loss, Tops Revenue Estimates

Flora Growth Corp. (FLGC) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -83.33%. A quarter ago, it was expected that this company would post a loss of $0.01 per share when it actually produced a loss of $0.04, delivering a surprise of -300%. Over the last four quarters, the company has not been able to surpass consensus EPS estimates. Flora Growth, which belongs to the Zacks Medical - Products industry, posted revenues of $14.8 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 25.71%. This compares to year-ago revenues of $15.68 million. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Flora Growth shares have lost about 42.9% since the beginning of the year versus the S&P 500's gain of 7.8%. What's Next for Flora Growth? While Flora Growth has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Flora Growth was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.06 on $12.52 million in revenues for the coming quarter and -$0.40 on $47.63 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Products is currently in the bottom 26% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Another stock from the same industry, Allurion Technologies, Inc. (ALUR), has yet to report results for the quarter ended June 2025. This company is expected to post quarterly loss of $0.65 per share in its upcoming report, which represents a year-over-year change of -360%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. Allurion Technologies, Inc.'s revenues are expected to be $5.95 million, down 49.5% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Flora Growth Corp. (FLGC) : Free Stock Analysis Report Allurion Technologies, Inc. (ALUR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Why AppLovin (APP) Dipped More Than Broader Market Today
Why AppLovin (APP) Dipped More Than Broader Market Today

Yahoo

time12 minutes ago

  • Yahoo

Why AppLovin (APP) Dipped More Than Broader Market Today

In the latest close session, AppLovin (APP) was down 2.95% at $379.17. This change lagged the S&P 500's daily loss of 1.6%. Elsewhere, the Dow saw a downswing of 1.23%, while the tech-heavy Nasdaq depreciated by 2.24%. Shares of the mobile app technology company have appreciated by 14.36% over the course of the past month, outperforming the Business Services sector's loss of 1.38%, and the S&P 500's gain of 2.25%. The investment community will be paying close attention to the earnings performance of AppLovin in its upcoming release. The company is slated to reveal its earnings on August 6, 2025. The company is expected to report EPS of $1.99, up 123.6% from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $1.21 billion, showing a 12.34% escalation compared to the year-ago quarter. For the full year, the Zacks Consensus Estimates are projecting earnings of $8.39 per share and revenue of $5.51 billion, which would represent changes of +85.21% and +17.02%, respectively, from the prior year. Investors should also note any recent changes to analyst estimates for AppLovin. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook. Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system. Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.03% increase. AppLovin is currently a Zacks Rank #3 (Hold). In the context of valuation, AppLovin is at present trading with a Forward P/E ratio of 46.54. This indicates a premium in contrast to its industry's Forward P/E of 21.61. We can additionally observe that APP currently boasts a PEG ratio of 2.33. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. By the end of yesterday's trading, the Technology Services industry had an average PEG ratio of 1.79. The Technology Services industry is part of the Business Services sector. This industry, currently bearing a Zacks Industry Rank of 97, finds itself in the top 40% echelons of all 250+ industries. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Make sure to utilize to follow all of these stock-moving metrics, and more, in the coming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AppLovin Corporation (APP) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store